Schedule of restatement impact |
|
|
|
|
|
|
|
|
|
|
|
|
As Previously Reported
|
|
Adjustments
|
|
As Restated
|
Balance sheet as of December 7, 2020
|
|
|
|
|
|
|
|
|
|
Warrant liabilities
|
|
$
|
—
|
|
$
|
43,147,500
|
|
$
|
43,147,500
|
Total Liabilities
|
|
|
12,683,050
|
|
|
43,147,500
|
|
|
55,830,550
|
Ordinary shares subject to possible redemption
|
|
|
329,793,740
|
|
|
(43,147,500)
|
|
|
286,466,240
|
Class A ordinary shares
|
|
|
152
|
|
|
432
|
|
|
584
|
Accumulated deficit
|
|
|
(5,000)
|
|
|
(1,583,878)
|
|
|
(1,588,878)
|
Additional paid-in-capital
|
|
|
5,003,995
|
|
|
1,583,447
|
|
|
6,587,441
|
Total Shareholder's Equity
|
|
|
5,000,010
|
|
|
—
|
|
|
5,000,010
|
Balance sheet as of December 31, 2020
|
|
|
|
|
|
|
|
|
|
Warrant liabilities
|
|
$
|
—
|
|
$
|
43,147,500
|
|
$
|
43,147,500
|
Total Liabilities
|
|
|
12,779,640
|
|
|
43,147,500
|
|
|
55,927,140
|
Ordinary shares subject to possible redemption
|
|
|
329,615,170
|
|
|
(43,147,500)
|
|
|
286,467,670
|
Class A ordinary shares
|
|
|
154
|
|
|
431
|
|
|
585
|
Accumulated deficit
|
|
|
(183,573)
|
|
|
(1,583,878)
|
|
|
(1,767,451)
|
Additional paid-in-capital
|
|
|
5,182,563
|
|
|
1,583,447
|
|
|
6,766,010
|
Total Shareholder's Equity
|
|
|
5,000,007
|
|
|
—
|
|
|
5,000,007
|
Net loss from September 11, 2020 to December 31, 2020
|
|
|
|
|
|
|
|
|
|
Transaction costs allocated to warrant liabilities
|
|
$
|
—
|
|
$
|
1,583,878
|
|
$
|
1,583,878
|
Net loss
|
|
|
(183,573)
|
|
|
(1,583,878)
|
|
|
(1,767,451)
|
Basic and diluted net loss per share, Class B
|
|
|
(0.02)
|
|
|
(0.21)
|
|
|
(0.23)
|
Cash flow from September 11, 2020 to December 31, 2020
|
|
|
|
|
|
|
|
|
|
Transaction costs allocated to warrant liabilities
|
|
$
|
—
|
|
$
|
1,583,878
|
|
$
|
1,583,878
|
Net loss
|
|
|
(183,573)
|
|
|
(1,583,878)
|
|
|
(1,767,451)
|
|